Introduction

GLP‑1 medicines are powerful tools for weight management and type 2 diabetes, but they can interact with other drugs and are unsuitable for certain health conditions. Before starting treatment, it’s essential to share your full medication list and medical history with a qualified prescriber. At MedCare Health Clinic & Pharmacy, our UK‑registered prescribers and pharmacists provide thorough assessments to ensure GLP‑1 therapy is safe for you.

Medicines to Discuss With Your Prescriber

Some medications can interact with GLP‑1 therapies, affecting either drug’s effectiveness or increasing side‑effect risks. Always tell your prescriber about all prescriptions, over‑the‑counter medicines and supplements you use.

1. Other Diabetes Medications

GLP‑1 medicines rarely cause low blood sugar (hypoglycaemia) when taken alone, but hypos can occur when they’re combined with insulin or sulfonylurea medicines [2]. Your healthcare team may reduce the dose of insulin or sulfonylurea to lower this risk [3].

2. Beta‑Blockers

Beta‑blockers (used for high blood pressure or heart problems) can mask warning signs of hypoglycaemia such as tremors or palpitations [4]. If you take a beta‑blocker, monitor your blood glucose carefully and report any unusual symptoms to your prescriber.

3. Warfarin & Other Blood Thinners

Some GLP‑1 drugs, such as exenatide and liraglutide, may enhance the anticoagulant effect of warfarin [4]. Your prescriber might recommend extra INR monitoring or adjust your warfarin dose.

4. Paracetamol & Other Oral Medications

Delayed gastric emptying from GLP‑1 therapy can affect the absorption of oral drugs. For example, lixisenatide can reduce paracetamol absorption when taken 1–4 hours before paracetamol [4]. To ensure proper absorption, certain oral medications should be taken at least 1 hour before or 4 hours after your GLP‑1 injection [4]. Ask your prescriber for personalised instructions.

5. Oral Contraceptives

The dual‑incretin GLP‑1/GIP drug tirzepatide may reduce the absorption of oral contraceptives [4]. Women using tirzepatide should switch to a non‑oral method or add a barrier method during the first four weeks of treatment and after each dose escalation[4]. Other GLP‑1 medicines can also slow gastric emptying, so if you use oral contraception, discuss reliable alternatives with your prescriber.

6. Medicines That Enhance or Reduce GLP‑1 Effects

GLP‑1 medicines’ blood‑glucose–lowering effects may be enhanced by alcohol, anabolic steroids, disopyramide, MAOIs or testosterone, and antagonised by corticosteroids, thiazide or loop diuretics, oestrogens and progestogens [4]. Your prescriber can advise whether dose adjustments or extra monitoring are necessary.

7. Stomach‑Motility Medicines

Because GLP‑1 drugs already slow stomach emptying, additional medicines that alter gut motility (e.g., certain anti‑diarrhoeals or prokinetics) could cause unpredictable absorption. Always mention these medications to your prescriber for advice.

Medical Conditions Requiring Caution or Avoidance

GLP‑1 therapy isn’t suitable for everyone. Here are key conditions that may require caution or mean a GLP‑1 medicine shouldn’t be prescribed.

1. Ketoacidosis and Pancreatitis

Do not use GLP‑1 medicines if you have a history of diabetic ketoacidosis or pancreatitis [1]. If severe upper abdominal pain occurs, stop your GLP‑1 and seek urgent medical help [3].

2. Kidney & Liver Impairment

Severe kidney or liver problems can make some GLP‑1 drugs unsafe. Avoid exenatide and liraglutide if your eGFR is below 30 mL/min/1.73 m² [1]; avoid exenatide modified‑release if eGFR is below 50 [1]; and avoid liraglutide and semaglutide in end‑stage renal disease or severe liver disease [1]. Talk to your prescriber about dose adjustments for mild‑to‑moderate renal or hepatic impairment.

3. Severe Gastrointestinal Disease

GLP‑1 medicines are not recommended in people with severe gastrointestinal disease such as diabetic gastroparesis or inflammatory bowel disease[1][3]. The delayed gastric emptying caused by GLP‑1 therapy can worsen these conditions.

4. Eye Complications

Patients with diabetic retinopathy should use caution. Semaglutide has been linked to potential worsening of retinopathy, especially when used with insulin[2]. If you have eye disease, your prescriber will assess the risks and may monitor your vision more closely.

5. Pregnant or Planning Pregnancy

GLP‑1 medicines are not recommended during pregnancy, when pregnancy is planned, or while breastfeeding [3]. Women of childbearing potential should discuss effective contraception with their prescriber [1].

6. Thyroid & Hormonal Conditions

Some GLP‑1 drugs are contraindicated in people with a history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2 [1]. People taking hormone replacement therapy (HRT) should seek a medication review, as certain GLP‑1 medicines can affect HRT effectiveness.

7. Heart Failure & Elderly Patients

GLP‑1 medicines may cause weight loss, which can impact frail or elderly people; caution is advised [1]. Patients with severe heart failure should also use liraglutide or semaglutide cautiously [1].

Practical Interaction Tips

To get the most benefit while avoiding interactions:

Space oral medications: Take certain oral drugs at least 1 hour before or 4 hours after your GLP‑1 injection [4][3]. Your prescriber or pharmacist can tell you which medicines need spacing.
Monitor for hypos: If you take insulin or a sulfonylurea, test your blood glucose more frequently and be ready to treat hypoglycaemia with fast‑acting carbohydrates [2][3].
Adjust doses carefully: Never change the dose of your GLP‑1 medicine (or your other medications) without prescriber advice. Dose reductions may be needed when combining with other drugs.
Be cautious with alcohol: Alcohol may amplify the blood‑glucose‑lowering effect of GLP‑1 medicines [4]. Drink in moderation and avoid binge drinking.
Remember oral contraceptives: If you take oral contraception and start tirzepatide, use non‑oral contraception or a barrier method for four weeks after starting or increasing the dose [4].
Follow sick‑day rules: If you’re unwell with vomiting or diarrhoea, contact your prescriber. You may need to pause your GLP‑1 medicine temporarily to avoid dehydration or poor drug absorption [2].

When to Avoid or Pause GLP‑1 Therapy

Stop your GLP‑1 medicine and seek urgent medical advice if you experience:

Severe or persistent abdominal pain (possible pancreatitis)k[3].
Symptoms of diabetic ketoacidosis (nausea, vomiting, abdominal pain, rapid breathing).
Pregnancy or planning pregnancy [3].
New or worsening eye problems [2].
Severe dehydration or persistent vomiting/diarrhoea.

Your prescriber may also advise temporarily pausing GLP‑1 therapy before certain surgical procedures or during prolonged fasting.

FAQs

Can I use GLP‑1 medicines with metformin?
Yes. GLP‑1 therapies are often prescribed alongside metformin. However, if you’re also taking a sulfonylurea or insulin, your prescriber may reduce those doses to prevent hypoglycaemia [2][3].

Do GLP‑1 drugs interact with blood pressure tablets?
Most blood pressure medicines are safe, but beta‑blockers can mask hypoglycaemia symptoms [4], and diuretics may reduce the efficacy of GLP‑1 medicines [4]. Always discuss your specific tablets with your prescriber.

What if I’m on oral contraception?
If you’re taking tirzepatide, use non‑oral contraception or a barrier method for four weeks after starting or increasing the dose 4]. Other GLP‑1 medicines may still slow absorption; speak to your prescriber about reliable contraceptive options.

Is it safe during pregnancy or breastfeeding?
No. GLP‑1 medicines are not recommended during pregnancy, when pregnancy is planned, or while breastfeeding [3]. Alternative treatments should be considered.

MedCare Health Clinic & Pharmacy

Located in Preston, MedCare Health Clinic & Pharmacy provides:

Comprehensive GLP‑1 assessments with UK‑registered prescribers.
Expert pharmacist advice on drug interactions, side effects and lifestyle support.
Next‑day delivery across England from our GPhC‑registered pharmacy.
Local support for patients in Lancashire, Manchester, Liverpool and across the UK.

We ensure your GLP‑1 treatment is safe, personalised, and aligned with NHS and NICE guidelines.

Disclaimer

This article is for UK residents only and does not replace professional medical advice. Always consult your GP, NHS 111, or a qualified prescriber for individual guidance. Suitability and dosing of GLP‑1 therapy are determined by a licensed prescriber based on your health history and current medicines.

Call to Action

Concerned about interactions or contraindications with GLP‑1 therapy?

👉 Start your secure online assessment today with MedCare Health Clinic & Pharmacy. Our UK prescribers and pharmacists will review your medicines and health conditions to ensure GLP‑1 treatment is safe and effective for you.

References

NICE Clinical Knowledge Summaries – GLP‑1 receptor agonists (Diabetes – Type 2): Contraindications and cautions include ketoacidosis, pancreatitis, severe renal or hepatic impairment, severe gastrointestinal disease, and caution in elderly patients or those with thyroid diseasecks.nice.org.uk.
Diabetes UK – GLP‑1 agonists: GLP‑1 therapies rarely cause hypoglycaemia alone but hypos can occur when combined with insulin or sulfonylureas; dose reductions may be necessarydiabetes.org.uk. The same source notes potential worsening of diabetic retinopathy when starting semaglutide with insulindiabetes.org.uk.
KnowDiabetes (North West London) – GLP‑1 receptor agents guidelines: GLP‑1 medicines are not recommended in people with severe gastrointestinal disease; pregnancy or planned pregnancy; require caution when combined with sulfonylurea or insulin due to increased risk of hypoglycaemia; and some oral medications should be taken at least 1 hour before or 4 hours after the GLP‑1 injectionknowdiabetes.org.uk.
NICE Clinical Knowledge Summaries – Drug interactions (GLP‑1 receptor agonists): Lists potential interactions with beta‑blockers, paracetamol, warfarin, oral contraceptives (especially tirzepatide), and other orally administered drugs; suggests spacing certain medications to avoid absorption issues; notes drugs that enhance or antagonise GLP‑1 effectscks.nice.org.uk.
NICE Clinical Knowledge Summaries – Oral contraceptive guidance for tirzepatide: Advises switching to non‑oral contraception or adding a barrier method for women using tirzepatide due to reduced absorption of oral contraceptivescks.nice.org.uk.
NHS/KnowDiabetes – GLP‑1 advice: Highlights that severe and persistent abdominal pain may indicate pancreatitis; GLP‑1 should be discontinued if confirmedknowdiabetes.org.uk.